Kalle Sigfridsson

Showing 10 publications

2015

A small structural change resulting in improved properties for product development

Kalle Sigfridsson, Thomas Andersson, Veronica Berntsson et al
Drug Development and Industrial Pharmacy. Vol. 41 (5), p. 866-873
Journal article
2014

Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to rats

Kalle Sigfridsson, A. Lundqvist, Marie Strimfors
Drug Development and Industrial Pharmacy. Vol. 40 (4), p. 511-518
Journal article
2014

Evaluation of systemic exposure of nanoparticle suspensions subcutaneously administered to mice regarding stabilization, volume, location, concentration and size

Kalle Sigfridsson, M. Palmer
Drug Development and Industrial Pharmacy. Vol. 40 (10), p. 1318-1324
Journal article
2013

Early pharmaceutical evaluation of a crystalline and hygroscopic GABA(B) receptor agonist

Kalle Sigfridsson, Thomas Andersson, Veronica Berntsson et al
Drug Development and Industrial Pharmacy. Vol. 39 (10), p. 1573-1581
Journal article
2013

Evaluation of exposure properties after injection of nanosuspensions and microsuspenions into the intraperitoneal space in rats

Kalle Sigfridsson, Anders Lundqvist, Marie Strimfors
Drug Development and Industrial Pharmacy. Vol. 39 (11), p. 1832-1839
Journal article
2012

Preformulation evaluation of AZD1305, an oxabispidine intended for oral and intravenous treatment

Kalle Sigfridsson, R. Lundqvist, K. Ohlson
Drug Development and Industrial Pharmacy. Vol. 38 (1), p. 19-31
Journal article
2011

Early development evaluation of AZD8081: a substrate for the NK receptors

Kalle Sigfridsson, M. Ahlqvist, A. Carlsson et al
Drug Development and Industrial Pharmacy. Vol. 37 (6), p. 702-713
Journal article
2011

Usefulness of a Nanoparticle Formulation to Investigate Some Hemodynamic Parameters of a Poorly Soluble Compound

Kalle Sigfridsson, J. A. Bjorkman, P. Skantze et al
Journal of Pharmaceutical Sciences. Vol. 100 (6), p. 2194-2202
Journal article
2011

Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor-the importance of gastrointestinal pH and solubility for the in vivo exposure

Kalle Sigfridsson, A. Lundqvist, Marie Strimfors
Drug Development and Industrial Pharmacy. Vol. 37 (9), p. 1036-1042
Journal article
2011

Early development evaluation of AZD2738, a substrate for the NK receptors

Kalle Sigfridsson, M. Ahlqvist, M. Lindsjo et al
Drug Development and Industrial Pharmacy. Vol. 37 (6), p. 719-726
Journal article

Save references

If you have installed Zotero or Mendeley on your computer you can use a plugin to extract references from the publications you see.

Download plugins:
Zotero
Mendeley

There are no projects.
There might be more projects where Kalle Sigfridsson participates, but you have to be logged in as a Chalmers employee to see them.